Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

Cereno Scientific B

Ylin-
Alin-
Vaihto-
2026 Q2 -tulosraportti

Äänite tulossa

1 päivä sitten

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 Q3 -tulosraportti
4.11.
Menneet tapahtumat
2026 Q2 -tulosraportti
26.8.
2026 Q1 -tulosraportti
27.5.
2025 Q4 -tulosraportti
27.2.
2025 Q3 -tulosraportti
27.11.2025
2025 Q2 -tulosraportti
27.8.2025

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 1 päivä sitten
    ·
    The report shows that the economy is strained. The high market capitalization is in danger.
    16 t sitten
    ·
    Buying more and still think you are far above average negative and speculate on your agenda in here.......
  • 1 päivä sitten
    ·
    Not easy to interpret today's report? But more money will be needed in 6 months - again!? After just received 60 million!? Burn rate of 10 million a month!! Hmmm…. One probably needs to ponder a bit here.
    2 t sitten
    ·
    Just a little fun fact. Acelleron pharma was acquired by Merch for 11.5 billion USD. We now have 311,365,076 Shares at Cereno so acquisition price divided by current shares equals a price of approx 37 USD. So yes, the potential is enormous here. Also, I should add that Sota was in PHASE 3 during the acquisition and we can expect a decent dilution before we can look at a possible, perhaps acquisition. The potential is there but a crazy long way to go 👌
  • 19.8.
    ·
    I've been well over 100% up, now I'm under 10%. I'm heavily invested, of course regretting not selling at the top. Now the question is? Should one sell or wait until one is left holding the bag?
    1 päivä sitten
    ·
    I sold a few months ago, only have some listening posts left. I have and had faith in the company, i.e. the product. But I've been involved since the dawn of time, I've been through the infamous spiral bank financing as well as share issues and not least when the financial supervisory authority made its entry. I eventually had a low average cost and a good number of shares, i.e. about 400k. Started selling at just over 6.5 kroner. When the sale was completed, I saw that the price was pulled down below 5, Myrild probably also sold some. So the idea was to rather chase after than lose most of it. The chase hasn't started yet. But I've taken note of what Sten has said, keep your shares, we have many stakeholders etc. Strange that this didn't affect the share price, was the fluidda study difficult or. I feel that critical questions have been shot down all the way, Sten has almost promised a deal this year, is it by the end of 2026 or from the time it was said, I hope for a deal, but I think the deal will be an insanely bad share issue. But I hope I'm wrong, after all, they have traveled the globe many times in recent years, and all meetings are fully booked but it didn't show in the share price, so I think one should also be critical and for example ask why Myrild didn't show up last time.
  • Julkaisu on poistettu.
    13.8.
    ·
    Data analysis and type of results 2028. What does the financing look like for this global study?? one might wonder?? 💭🤔
  • 11.8.
    ·
    Been in this for a long time. But feel more and more That management is making fools of us. Deal during 2026. Start of Phase 2b. Time for Sten and the gang to come back from vacation 🤔… let's debate 💪
    11.8.
    ·
    Hard to keep interest high and broad with 1 patient.?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2026 Q2 -tulosraportti

Äänite tulossa

1 päivä sitten

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 1 päivä sitten
    ·
    The report shows that the economy is strained. The high market capitalization is in danger.
    16 t sitten
    ·
    Buying more and still think you are far above average negative and speculate on your agenda in here.......
  • 1 päivä sitten
    ·
    Not easy to interpret today's report? But more money will be needed in 6 months - again!? After just received 60 million!? Burn rate of 10 million a month!! Hmmm…. One probably needs to ponder a bit here.
    2 t sitten
    ·
    Just a little fun fact. Acelleron pharma was acquired by Merch for 11.5 billion USD. We now have 311,365,076 Shares at Cereno so acquisition price divided by current shares equals a price of approx 37 USD. So yes, the potential is enormous here. Also, I should add that Sota was in PHASE 3 during the acquisition and we can expect a decent dilution before we can look at a possible, perhaps acquisition. The potential is there but a crazy long way to go 👌
  • 19.8.
    ·
    I've been well over 100% up, now I'm under 10%. I'm heavily invested, of course regretting not selling at the top. Now the question is? Should one sell or wait until one is left holding the bag?
    1 päivä sitten
    ·
    I sold a few months ago, only have some listening posts left. I have and had faith in the company, i.e. the product. But I've been involved since the dawn of time, I've been through the infamous spiral bank financing as well as share issues and not least when the financial supervisory authority made its entry. I eventually had a low average cost and a good number of shares, i.e. about 400k. Started selling at just over 6.5 kroner. When the sale was completed, I saw that the price was pulled down below 5, Myrild probably also sold some. So the idea was to rather chase after than lose most of it. The chase hasn't started yet. But I've taken note of what Sten has said, keep your shares, we have many stakeholders etc. Strange that this didn't affect the share price, was the fluidda study difficult or. I feel that critical questions have been shot down all the way, Sten has almost promised a deal this year, is it by the end of 2026 or from the time it was said, I hope for a deal, but I think the deal will be an insanely bad share issue. But I hope I'm wrong, after all, they have traveled the globe many times in recent years, and all meetings are fully booked but it didn't show in the share price, so I think one should also be critical and for example ask why Myrild didn't show up last time.
  • Julkaisu on poistettu.
    13.8.
    ·
    Data analysis and type of results 2028. What does the financing look like for this global study?? one might wonder?? 💭🤔
  • 11.8.
    ·
    Been in this for a long time. But feel more and more That management is making fools of us. Deal during 2026. Start of Phase 2b. Time for Sten and the gang to come back from vacation 🤔… let's debate 💪
    11.8.
    ·
    Hard to keep interest high and broad with 1 patient.?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 Q3 -tulosraportti
4.11.
Menneet tapahtumat
2026 Q2 -tulosraportti
26.8.
2026 Q1 -tulosraportti
27.5.
2025 Q4 -tulosraportti
27.2.
2025 Q3 -tulosraportti
27.11.2025
2025 Q2 -tulosraportti
27.8.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

2026 Q2 -tulosraportti

Äänite tulossa

1 päivä sitten

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 Q3 -tulosraportti
4.11.
Menneet tapahtumat
2026 Q2 -tulosraportti
26.8.
2026 Q1 -tulosraportti
27.5.
2025 Q4 -tulosraportti
27.2.
2025 Q3 -tulosraportti
27.11.2025
2025 Q2 -tulosraportti
27.8.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 1 päivä sitten
    ·
    The report shows that the economy is strained. The high market capitalization is in danger.
    16 t sitten
    ·
    Buying more and still think you are far above average negative and speculate on your agenda in here.......
  • 1 päivä sitten
    ·
    Not easy to interpret today's report? But more money will be needed in 6 months - again!? After just received 60 million!? Burn rate of 10 million a month!! Hmmm…. One probably needs to ponder a bit here.
    2 t sitten
    ·
    Just a little fun fact. Acelleron pharma was acquired by Merch for 11.5 billion USD. We now have 311,365,076 Shares at Cereno so acquisition price divided by current shares equals a price of approx 37 USD. So yes, the potential is enormous here. Also, I should add that Sota was in PHASE 3 during the acquisition and we can expect a decent dilution before we can look at a possible, perhaps acquisition. The potential is there but a crazy long way to go 👌
  • 19.8.
    ·
    I've been well over 100% up, now I'm under 10%. I'm heavily invested, of course regretting not selling at the top. Now the question is? Should one sell or wait until one is left holding the bag?
    1 päivä sitten
    ·
    I sold a few months ago, only have some listening posts left. I have and had faith in the company, i.e. the product. But I've been involved since the dawn of time, I've been through the infamous spiral bank financing as well as share issues and not least when the financial supervisory authority made its entry. I eventually had a low average cost and a good number of shares, i.e. about 400k. Started selling at just over 6.5 kroner. When the sale was completed, I saw that the price was pulled down below 5, Myrild probably also sold some. So the idea was to rather chase after than lose most of it. The chase hasn't started yet. But I've taken note of what Sten has said, keep your shares, we have many stakeholders etc. Strange that this didn't affect the share price, was the fluidda study difficult or. I feel that critical questions have been shot down all the way, Sten has almost promised a deal this year, is it by the end of 2026 or from the time it was said, I hope for a deal, but I think the deal will be an insanely bad share issue. But I hope I'm wrong, after all, they have traveled the globe many times in recent years, and all meetings are fully booked but it didn't show in the share price, so I think one should also be critical and for example ask why Myrild didn't show up last time.
  • Julkaisu on poistettu.
    13.8.
    ·
    Data analysis and type of results 2028. What does the financing look like for this global study?? one might wonder?? 💭🤔
  • 11.8.
    ·
    Been in this for a long time. But feel more and more That management is making fools of us. Deal during 2026. Start of Phase 2b. Time for Sten and the gang to come back from vacation 🤔… let's debate 💪
    11.8.
    ·
    Hard to keep interest high and broad with 1 patient.?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt